Exact Mass: 291.03302840000003

N-(1H-Benzotriazol-1-yl)-2,4-dichlorobenzamide

C13H7Cl2N3O (290.9966152)

norsertraline

Cis-(+/-)-4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Naphthalenamine

norsertraline is a metabolite of sertraline. Sertraline hydrochloride (trademark names Zoloft and Lustral) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It was introduced to the market by Pfizer in 1991. Sertraline is primarily used to treat major depression in adult outpatients as well as obsessive–compulsive, panic, and social anxiety disorders in both adults and children. In 2007, it was the most prescribed antidepressant on the U.S. retail market, with 29,652,000 prescriptions. (Wikipedia) CONFIDENCE standard compound; EAWAG_UCHEM_ID 3623

Hawkinsin

2-Amino-3-{[2-(carboxymethyl)-2,5-dihydroxycyclohex-3-en-1-yl]sulphanyl}propanoic acid

Hawkinsin is a sulfur amino acid identified as (2-L-cystein-S-yl-1,4-dihydroxycyclohex-5-en-1-yl)acetic acid. It is a reactive byproduct of abnormal tyrosine metabolism. Normally, the breakdown of the amino acid tyrosine involves the conversion of 4-hydroxyphenylpyruvate to homogentisate by 4-hydroxyphenylpyruvate dioxygenase. Complete deficiency of this enzyme leads to an inborn error of metabolism called tyrosinemia III. In rare cases, however, the enzyme is still able to produce the reactive intermediate 1,2-epoxyphenyl acetic acid but is unable to convert this intermediate to homogentisate (PMID: 11073718). The intermediate then spontaneously reacts with glutathione to form hawkinsin. Chronically high levels of hawkinsin are associated with hawkinsinuria (characterized by the inability to break down the amino acid tyrosine). Patients with hawkinsinuria excrete hawkinsin in their urine throughout their life. The features of this condition usually appear around the time infants are weaned off breast milk and begin to use formula. The signs and symptoms may include the following: failure to gain weight and grow at the expected rate (failure to thrive), abnormally high acid levels in the blood (acidosis), and fine or sparse hair. Hawkinsin is an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Hawkinsin is an organic acid. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated hawkinsinuria. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures. Hawkinsin is a sulfur amino acid identified as (2-l-cystein-S-yl, 4-dihydroxycyclohex-5-en-1-yl)acetic acid. Patients with hawkinsinuria excrete this metabolite in their urine throughout their life, although symptoms of metabolic acidosis and tyrosinemia improve in the first year of life. Alterations in the structure and activity of 4-hydroxyphenylpyruvic acid dioxygenase are causally related to two different metabolic disorders, tyrosinemia type III and hawkinsinuria. (PMID 11073718) [HMDB]

Orciprenaline-3-O-sulfate

(3-hydroxy-5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}phenyl)oxidanesulfonic acid

Orciprenaline-3-O-sulfate is a metabolite of orciprenaline. Orciprenaline is a bronchodilator used in the treatment of asthma. Orciprenaline is a moderately selective beta2-adrenergic receptor agonist that stimulates receptors of the smooth muscle in the lungs, uterus, and vasculature supplying skeletal muscle, with minimal or no effect on alpha-adrenergic receptors. (Wikipedia)

Acetamide, N-[4-[(2-pyridinylamino)sulfonyl]phenyl]-

N-{4-[(pyridin-2-yl)sulphamoyl]phenyl}ethanimidic acid

D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

2',3'-Dideoxycytidine-5'-monophosphate

{[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}phosphonic acid

C9H14N3O6P (291.0620194)

Cloranolol

1-(2,5-Dichlorophenoxy)-3-tertiary-butylamino-2-propanol

C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Lobenzarit

2-[(2-carboxyphenyl)amino]-4-chlorobenzoic acid

C12H13N5O2S (291.07899180000004)

Prontosil

4-[2-(2,4-Diaminophenyl)diazen-1-yl]benzene-1-sulphonamide

N-[2,6-Dichloro-4-(2-chloroethyl)phenyl]-4,5-dihydro-1H-imidazol-2-amine

C11H12Cl3N3 (291.0096762)

Thiamethoxam

3-((2-Chloro-5-thiazolyl)methyl)tetrahydro-5-methyl-N-nitro-4H-1,3,5-oxadiazin-4-imine

C8H10ClN5O3S (291.0192860000001)

Tifenazoxide

6-chloro-3-[(1-methylcyclopropyl)imino]-2H,3H,4H-1lambda6-thieno[3,2-e][1,2,4]thiadiazine-1,1-dione

C9H10ClN3O2S2 (290.990295)

zomepirac

5-(4-Chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetate dihydrate

C10H14NO5PS (291.03302840000003)

M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

parathion

D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 3115 D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals

norsertraline

Cis-(+/-)-4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Naphthalenamine

CONFIDENCE standard compound; EAWAG_UCHEM_ID 3623 CONFIDENCE standard compound; INTERNAL_ID 1566

Indatraline

C8H10ClN5O3S (291.0192860000001)

C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

Thiamethoxam

Pesticide5_Thiamethoxam_C8H10ClN5O3S_4H-1,3,5-Oxadiazin-4-imine, 3-[(2-chloro-5-thiazolyl)methyl]tetrahydro-5-methyl-N-nitro-, (4E)-

D010575 - Pesticides > D007306 - Insecticides > D000073943 - Neonicotinoids D016573 - Agrochemicals

Zomepirac; AIF; CE0; CorrDec

Zomepirac; AIF; CE10; CorrDec

Zomepirac; AIF; CE30; CorrDec

Zomepirac; AIF; CE0; MS2Dec

Zomepirac; AIF; CE10; MS2Dec

Zomepirac; AIF; CE30; MS2Dec

Metaproterenol 3-O-sulfate

Desmethylsertraline

N4-Acetylsulfapyridine

Zalcitabine monophosphate

C9H14N3O6P (291.0620194)

5-BROMO-2-PHENYLAMINO-BENZOIC ACID

C12H10ClN5S (291.03454100000005)

2-Chloro-N-(5-cyclopropyl-1H-pyrazol-3-yl)thieno[3,2-d]pyrimidin- 4-amine

Ketone 2-amino-4,5,6,7-tetrahydrobenzo[b]thien-3-yl o-chlorophenyl

C15H14ClNOS (291.0484584)

ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate

6-BROMO-2-PIPERAZIN-1-YL-QUINOLINE

C11H18ClN3O2S (291.08081980000003)

4-(1-Pyrrolidinylsulforylmenthyl)phenylhydrazine hydrochloride

n-isopropyl 3-bromo-4-methylbenzenesulfonamide

Amidapsone

C254 - Anti-Infective Agent > C849 - Sulfone Anti-Infective Agent

2-(3,4,5-trimethoxyphenyl)-1,3-thiazolidine,hydrochloride

C12H18ClNO3S (291.0695868)

2-(2-methyl-2H-pyridin-1-yl)-1-phenyl-ethanone

[2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methanol

C12H9F4NOS (291.0340952)

5-(chloromethyl)-4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole

C12H9ClF3NS (291.00963)

4-Chloro-2-methyl-3-(3-oxobutyl)quinoline-6-carboxylic acid

4-CHLORO-2-METHYL-3-(3-OXO-BUTYL)-QUINOLINE-6-CARBOXYLIC ACID

Azure A

7-Amino-N,N-dimethyl-3H-phenothiazin-3-iminium chloride

C14H14ClN3S (291.0596914)

D004396 - Coloring Agents > D001399 - Azure Stains

1-(4-BROMOBUTOXY)-4-METHYLBENZENE

4-(METHYL-PHENYL-SULFAMOYL)-BENZOIC ACID

C11H8F3NO3S (291.01769740000003)

4-(2-bromoacetamido)-2,2,6,6-tetramethyl-1-piperidinyloxy

C11H20BrN2O2 (291.070806)

3-OXO-6-(TRIFLUOROMETHYL)-3,4-DIHYDRO-2H-1,4-BENZOTHIAZIN-2-YL]ACETIC ACID

2-bromo-n-(4-hydroxyphenyl)benzamide

2-CHLORO-5-{[ISOPROPYL(METHYL)AMINO]SULFONYL}BENZOIC ACID

oxazepam-d5

C15H6ClD5N2O2 (291.08228749)

tert-butyl 3-(2-bromoacetyl)pyrrolidine-1-carboxylate

C11H18BrNO3 (291.0469978)

4-(6-bromopyridin-2-yl)-2-methylbenzoic acid

4-BROMO-2-(N-BOC-AMINOMETHYL)THIOPHENE

C11H15BrClNO (291.00254700000005)

4-(4-Bromophenoxy)piperidine hydrochloride (1:1)

5-(Benzyloxy)-6-bromopicolinaldehyde

4-bromo-N-butylbenzenesulfonamide

4-(4-Methylphenylsulfonamido)benzoic acid

C6H2F9NO2 (290.99418199999997)

2,3,5,6-TETRAFLUORO-4-(PHENYLSULPHONYL)PYRIDINE

C11H5F4NO2S (290.9977118)

2-HYDROXY-6-METHYL-3-NITROPYRIDINE

C12H15Cl2NO3 (291.042894)

Coumarin 175

C11H10NNaO5S (291.017737)

3,3,4,4,5,5,6,6,6-NONAFLUORO-1-NITRO-1-HEXENE

3-(2,5,5-Trimethyl-1,3-dioxan-2-yl)thiophene-2-sulfonamide

C11H17NO4S2 (291.0598962)

3-[(4-Amino-3-methylphenyl)azo]benzenesulfonic acid

C13H16Cl3N (291.03482660000003)

2,4,6-trichloro-N-(cyclohexylmethyl)aniline

n-acetyl-n-acetoxy-4-chlorobenzenesulfonamide

C10H10ClNO5S (290.99682)

3-CHLORO-4-METHOXY-3-NITROBENZOPHENONE

C11H15BrClNO (291.00254700000005)

4-(3-bromophenoxy)piperidine,hydrochloride

2-bromo-1-[6-(dimethylamino)naphthalen-2-yl]ethanone

2-(2-ETHOXYETHOXY)ANILINE

C11H15Cl2N3O2 (291.054127)

8-Bromo-2-(piperazin-1-yl)quinoline

1-(4-Bromophenyl)-N-propylmethanesulfonamide

C14H11Cl2N3 (291.03299860000004)

N-(3,4-dichlorophenyl)-N-methyl-1H-benzimidazol-2-amine

1,3-Dithietane-2-carboxylic acid, 4-[1-(aminocarbonyl)-2-(1,1-dimethylethoxy)-2-oxoethylidene]

C10H13NO5S2 (291.0235128)

5-(BENZYLOXY)-2-BROMO-4-METHYLANILINE

Lobenzarit

C11H15Cl2N3S (291.03636900000004)

D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C26170 - Protective Agent > C275 - Antioxidant D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

2-(5-(MORPHOLINOSULFONYL)THIOPHEN-2-YL)ACETIC ACID

C10H13NO5S2 (291.0235128)

4-bromo-n-isopropylamphetamine hydrochloride

C12H19BrClN (291.0389304)

3-(Piperazin-1-yl)benzo[d]isothiazole dihydrochloride

2-(5-CHLOROCARBONYL-2-OXAZOLYL)-5,6-METHYLENEDIOXYBENZOFURAN (OMB-COCL)

C13H6ClNO5 (290.9934496)

1-(4-Bromophenyl)-N-isopropylmethanesulfonamide

N-[4-(pyridin-3-ylsulfamoyl)phenyl]acetamide

4-BROMO-1-(PIPERAZIN-1-YL)ISOQUINOLINE

2-Bromo-N-(2-methyl-2-propanyl)benzenesulfonamide

2-Bromo-N,N-diethylbenzenesulfonamide

5-bromo-2-(pyridin-3-ylmethoxy)benzaldehyde

C11H9N5O3S (291.04260840000006)

(S)-(+)-NBD-PY-NCS

methyl 3-(6-bromopyridin-2-yl)benzoate

C18H13NOS (291.07178080000006)

1H-Benz[g]indole-3-carboxaldehyde,2-(5-methyl-2-thienyl)-(9CI)

2-(4-[(3,4-DICHLOROBENZYL)OXY]PHENYL)ACETONITRILE

C15H11Cl2NO (291.02176560000004)

ethyl 5-(methoxycarbonylsulfamoyl)-1-methylpyrazole-4-carboxylate

C9H13N3O6S (291.05250380000007)

N-t-Butyl 4-bromobenzenesulfonamide

3-(2-Bromoacetamidomethyl)-PROXYL3-(2-Bromoacetamidomethyl)-2,2,5,5-tetramethyl-1-pyrrolidinoxy

C11H20BrN2O2 (291.070806)

3-Bromo-N-(tert-butyl)benzenesulfonamide

C11H15BrClNO (291.00254700000005)

6-BROMO-2,2-DIMETHYLCHROMAN-4-AMINE

Radafaxine hydrochloride

Radafaxine (hydrochloride)

C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

Tert-butyl [4-(chlorosulfonyl)phenyl]carbamate

C14H10ClNO2S (291.01207500000004)

4-chloro-6-nitro-7-propan-2-yloxyquinoline-3-carbonitrile

C13H10ClN3O3 (291.041066)

1-(benzenesulfonyl)-6-chloroindole

5-bromo-N-(pyridin-3-ylmethyl)pyridine-3-carboxamide

C12H10BrN3O (291.000719)

2-(3-Bromo-phenylamino)-benzoic acid

C13H14BNO4S (291.07365540000006)

Benzyl (2,4-difluoro-3-formylphenyl)carbamate

C15H11F2NO3 (291.070696)

[3-(Benzylsulfamoyl)phenyl]boronic acid

2-Chloro-N-[4-(1H-indol-3-yl)-1,3-thiazol-2-yl]acetamide

C13H10ClN3OS (291.02330800000004)

4-(6-bromopyridin-2-yl)-3-methylbenzoic acid

C11H18ClN3O2S (291.08081980000003)

N-[2-(Piperazin-1-yl)phenyl]methylsulphonamide hydrochloride

6-BROMO-2-CYCLOPROPYLQUINOLINE-4-CARBOXYLICACID

C12H12F3NO4 (291.07183879999997)

3,3,3-trifluoro-2-methyl-2-(phenylmethoxycarbonylamino)propanoic acid

1-(4-bromo-3-methylphenyl)-2,5-dimethylpyrrole-3-carbaldehyde

CHEMBRDG-BB 6619297

3-[(4-methylphenyl)sulfonylamino]benzoate

Phenyl 2-amino-5-bromobenzoate

C14H11Cl2N3 (291.03299860000004)

1H-Indazol-5-amine, 1-[(3,4-dichlorophenyl)methyl]

METHYL 7-NITRO-5-OXO-3,5-DIHYDRO-2H-OXAZOLO[2,3-B]QUINAZOLINE-8-CARBOXYLATE

C12H9N3O6 (291.04913339999996)

ethyl (E)-3-(2-chlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate

C12H12F3NO4 (291.07183879999997)

2,3-PYRIDINEDICARBOXYLIC ACID, 5-(TRIFLUOROMETHYL)-, DIETHYL ESTER

2-[(4-methylphenyl)sulfonylamino]benzoic acid

2-{[METHYL(PHENYL)AMINO]SULFONYL}BENZOIC ACID

4-Chloro-3-diethylsulfaMoyl-benzoic acid

3-[(TERT-BUTYLAMINO)SULFONYL]-4-CHLOROBENZOIC ACID

1-(2,6-dichlorophenyl)indole-2,3-dione

C14H7Cl2NO2 (290.9853822)

2-(2,5-DIMETHOXYPHENYLTHIO)PYRIDINE-3-CARBOXYLIC ACID

tert-Butyl N-[(5-bromo-2-thienyl)methyl]carbamate

tert-butyl N-[(2-bromothiophen-3-yl)methyl]carbamate

C11H9N5O3S (291.04260840000006)

(R)-(-)-NBD-PY-NCS

MCLA hydrochloride

7-BENZYL-3-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,5-A]PYRAZINE

7-Amino-3-(1-pyridylmethyl)-3-cephem-4-carboxylic Acid

S)-2-((Methoxycarbonyl)amino)-3-Methylbutanoic acid

Rubber Accelerator SDBC

C9H18NS4Na (291.0219748)

2-chloro-N-(2,5-dimethoxyphenyl)benzamide

2,6-Dichloro-4-nitro-benzoic acid tert-butyl ester

C11H11Cl2NO4 (291.0065106)

(S,S)-Hydroxy Bupropion

C13H14BNO4S (291.07365540000006)

(5-((((Benzyloxy)carbonyl)amino)methyl)thiophen-2-yl)boronic acid

1-(5-Bromo-6-methylpyridin-2-yl)piperazine hydrochloride

C10H15BrClN3 (291.01378)

3-Bromo-5-methyl-N-propylbenzenesulfonamide

2-Bromo-N-butylbenzenesulfonamide

Benzamide,N-(4-bromophenyl)-2-hydroxy-

3-Bromo-N,N-diethylbenzenesulfonamide

ethyl 2-(2,3-dihydro-1,4-benzodioxin-3-yl)-1,3-thiazole-4-carboxylate

4-Bromo-N-isopropyl-3-methylbenzenesulfonamide

1,3-Diphenylguanidine hydrobromide (1:1)

7-BENZYL-1-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,5-A]PYRAZINE

C8H10IN3O (290.98686000000004)

4-(5-iodopyrimidin-4-yl)morpholine

N-(4-acetylphenyl)-4-hydroxybenzenesulfonamide

5-(3,5-dichlorophenyl)-3-pyridin-2-yl-1,2,4-oxadiazole

C13H7Cl2N3O (290.9966152)

4-Bromo-N,N-diethylbenzenesulfonamide

3-bromo-N-butylbenzenesulfonamide

C13H14BNO4S (291.07365540000006)

[4-(Benzylsulfamoyl)phenyl]boronic acid

6-BROMO-4-(PIPERAZIN-1-YL)QUINOLINE

C11H15ClNO4P (291.04271900000003)

3-Bromo-7-(furan-2-yl)-2,5-dimethylpyrazolo[1,5-a]pyrimidine

C12H10BrN3O (291.000719)

(2S)-ETHYL 2-((CHLORO(PHENOXY)PHOSPHORYL)AMINO)PROPANOATE

Dasotraline

C78272 - Agent Affecting Nervous System

(2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)(4-chlorophenyl)methanone

C15H14ClNOS (291.0484584)

Cytidine 5-monophosphate

2,3-Dideoxycytidine-5-monophosphate

C9H14N3O6P (291.0620194)

5-Methyl-2-[(phenylsulfonyl)amino]benzoic acid

Tifenazoxide

C9H10ClN3O2S2 (290.990295)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent

6-(3-Bromophenyl)-2-methylnicotinic acid

4-(4-Chlorophenyl)-2-(2-cyclopentylidenehydrazinyl)thiazole

C14H14ClN3S (291.0596914)

Karetazan

Alizarine Blue

C13H10FN3S2 (291.03001520000004)

N-(4-methylphenyl)sulfonylbenzenecarbothioamide

C14H13NO2S2 (291.0387678)

5-[2-(4-Fluoroanilino)vinyl]-3-(methylsulfanyl)-4-isothiazolecarbonitrile

3-[[(4-Methoxyphenyl)-oxomethyl]amino]-2-thiophenecarboxylic acid methyl ester

2-[[2-furanyl(oxo)methyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylic acid methyl ester

6-(4-Bromophenyl)-2-methylpyridine-3-carboxylic acid

N-acetyldichloro-L-tyrosine

C11H11Cl2NO4 (291.0065106)

alpha-Methyldopa-3-0-sulfate

C10H13NO7S (291.0412708)

(5r)-2-Sulfanyl-5-[4-(Trifluoromethyl)benzyl]-1,3-Thiazol-4-One

C11H8F3NOS2 (290.9999394)

Cloranolol

(2-l-cystein-S-yl-1,4-dihydroxycyclohex-5-en-1-yl)-acetic acid

C13H10ClN3OS (291.02330800000004)

13-Hydroxynorjavanicin

C14H11O7- (291.0504756)

2-methyl-N-(2,3,4,5,6-pentafluorophenyl)-3-furancarboxamide

C12H6F5NO2 (291.0318676)

4-(4-Chlorophenyl)-1-methyl-2-(methylthio)-6-oxo-5-pyrimidinecarbonitrile

2-{[3-(2-Furyl)acryloyl]amino}-4,5-dimethyl-3-thiophenecarboxylic acid

AT-Csc-07

N-(5-chloro-2-hydroxyphenyl)-2-ethoxybenzamide

N-(5-chloro-2-hydroxyphenyl)-2-(4-methoxyphenyl)acetamide

(3,5-Dichloro-2,4,6-trihydroxyphenyl)hexan-1-one(1-)

C12H13Cl2O4- (291.0190858)

A phenolate anion resulting from removal of the proton from the phenolic hydroxy group of (3,5-dichloro-2,4,6-trihydroxyphenyl)hexan-1-one that is para to the hexanoyl group. The major structure at pH 7.3.

5-nitro-2-[[5-(triluoromethyl)-1H-1,2,4-triazol-3-yl]sulanyl]pyridine

C8H4F3N5O2S (291.00378)

4-Hydroxy-3,6-dioxo-2,5-diphenylcyclohexa-1,4-dien-1-olate

C18H11O4- (291.0657306)

(2R)-2-amino-N-[4-chloro-2-[oxo(1H-pyrrol-2-yl)methyl]phenyl]propanamide

3-amino-N-[4-chloro-2-[oxo(1H-pyrrol-2-yl)methyl]phenyl]propanamide

C13H12BrN2O+ (291.01329419999996)

6-Bromoharminium(1+)

2-bromo-N-[2-(2-naphthalenyl)ethyl]acetamide

C10H14NO5PS (291.03302840000003)

parathion

D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals

brimonidine

C11H10BrN5 (291.011952)

S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EA - Sympathomimetics in glaucoma therapy S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics > S01GA - Sympathomimetics used as decongestants C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D - Dermatologicals Brimonidine (UK 14304) is a full α2-adrenergic receptor (α2-AR) agonist.

Acetamide, N-[4-[(2-pyridinylamino)sulfonyl]phenyl]-

D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

Hawkinsin

A cysteine derivative that is cysteine in which the thiol group is substituted by a [2-(carboxymethyl)-2,5-dihydroxycyclohex-3-en-1-yl]sulfanediyl group. Hawkinsinuria is an inherited disorder which is characterized by the inability to break down the amino acid tyrosine. This results in the finding of certain metabolites in the urine, such as hawkinsin.

Orciprenaline-3-O-sulfate

16-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14,16,18-octaen-13-one

methyl 4-methoxy-5-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]furo[2,3-b]pyridine-6-carboxylate

C14H13NO6 (291.0742838)

(e)-n-({5-[(r)-methanesulfinyl]-4-methoxy-[2,2'-bipyridin]-6-yl}methylidene)hydroxylamine

methyl 4-methoxy-5-(3-methoxy-3-oxoprop-1-en-1-yl)furo[2,3-b]pyridine-6-carboxylate

C14H13NO6 (291.0742838)

10-hydroxyliriodenine